Articles From: IIROC Trading Halt - EVT to Itron Authorizes $50 Million Share Repurchase Program


2014/2/12
IIROC Trading Halt - EVT Canada NewsWire TORONTO , Feb.
Sign-up for IIROC Trading Halt - EVT investment picks
2014/2/12
http://media.marketwire.com/attachments/201305/153616_60427_ADPlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1089150&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for Illinois Added 6,960 Private Sector Jobs in January, According to ADP Regional Employment Report(SM) investment picks
2014/2/12
Illumina, Inc. (NASDAQ:ILMN) today announced the launch of the Illumina Accelerator Program, the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry.
Sign-up for Illumina Launches the Illumina Accelerator Program, World’s First Genomics Incubator investment picks
2014/2/12
ST. PAUL, Minn., Feb.
Sign-up for Image Sensing Systems Announces Partnership with CA Traffic and the Release of New LPR Camera investment picks
2014/2/12
Imperial Holdings, Inc. (NYSE: IFT) (“Imperial”) announced today the pricing of $70,000,000 aggregate principal amount of 8.50% Senior Unsecured Convertible Notes Due 2019 (the “Notes”), which are anticipated to be sold, subject to market and other conditions, to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to accredited investors pursuant to Rule 506 under the Securities Act.
Sign-up for Imperial Announces the Pricing of $70 Million of Senior Unsecured Convertible Notes investment picks
2014/2/12
Incyte Corporation (Nasdaq: INCY) today reported 2013 fourth-quarter and year-end financial results, including revenue from Jakafi ® (ruxolitinib), which is approved by the U.S. Food & Drug Administration (FDA) for the treatment of patients with intermediate or high-risk myelofibrosis (MF). The Company also provided 2014 financial guidance and highlighted multiple achievements in its clinical programs, including agreement with the FDA for a Special Protocol Assessment (SPA) for a registration trial of ruxolitinib in patients with advanced or metastatic pancreatic cancer.
Sign-up for Incyte Reports 2013 Fourth-Quarter and Year-End Financial Results; Provides 2014 Financial Guidance; Updates Shareholders on Key Clinical Programs investment picks
2014/2/12
MCKINNEY, Texas, Feb.
Sign-up for Independent Bank Group, Inc. Declares Quarterly Dividend investment picks
2014/2/12
Emulex Corporation (NYSE:ELX), a leader in network connectivity, monitoring and management, today announced the results of a commissioned study conducted by Forrester Consulting on behalf of Emulex.
Sign-up for Independent Research Study Finds Network Visibility Improves Incident Resolution Times for Network and Security Operations investment picks
2014/2/12
NEW YORK , Feb.
Sign-up for ING U.S. Announces Fourth Quarter and Full Year 2013 Results investment picks
2014/2/12
Fourth quarter adjusted non-GAAP diluted EPS of $1.06 exceeds analyst expectations ENGLEWOOD, Colo., Feb.
Sign-up for Innospec Reports Fourth Quarter and Full Year 2013 Financial Results investment picks
2014/2/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0927154001&sourceType=1 http://media3.marketwire.com/logos/20140207-InnVEST.jpg TORONTO, ONTARIO --
Sign-up for InnVest Real Estate Investment Trust Special Committee Update investment picks
2014/2/12
TEMPE, Ariz., Feb.
Sign-up for Insight Enterprises, Inc. Reports Fourth Quarter and Full Year 2013 Results investment picks
2014/2/12
MOUNT AIRY, N.C. , Feb.
Sign-up for Insteel Industries Declares Quarterly Cash Dividend investment picks
2014/2/12
http://media.marketwire.com/attachments/201305/60668_insys.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1089583&ProfileId=051205&sourceType=1 PHOENIX, AZ --
Sign-up for Insys Therapeutics to Report Fourth Quarter and Year-End 2013 Financial Results on March 4 investment picks
2014/2/12
SANDPOINT, Idaho, Feb.
Sign-up for Intermountain Community Bancorp Reports Fourth Quarter and Full Year 2013 Earnings investment picks
2014/2/12
Invacare Corporation (NYSE: IVC) today announced its decision to close its London, Canada manufacturing facility by mid-2014.
Sign-up for Invacare Corporation Announces Closure of London, Canada Manufacturing Facility investment picks
2014/2/12
Levi & Korsinsky commenced an investigation of the Board of Directors of AMCOL International Corporation (“AMCOL” or “the Company”) (NYSE: ACO) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Imerys S.A. Click here to learn more - http://zlk.9nl.com/amcol-international-aco , or call: 877-363-5972.
Sign-up for INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of AMCOL International Corporation and Its Board of Directors In Connection With the Sale of the Company to Imerys S.A. investment picks
2014/2/12
http://media.marketwire.com/attachments/201107/5424_LeviAndKorsinsky_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1089462&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for INVESTOR ALERT: LEVI & KORSINSKY, LLP Notifies Investors of ACCELRYS INC. of Claims of Breaches of Fiduciary Duty Against Board of Directors of Company in Connection With the Sale of the Company to Dassault Systemes SA -- ACCL investment picks
2014/2/12
Record $218.7 Million Quarterly Revenues and $64.2 Million Income from Operations Fourth Quarter Diluted EPS of $0.12 as Reported and $0.33 as Adjusted HOUSTON , Feb.
Sign-up for ION Reports Strong Fourth Quarter Results investment picks
2014/2/12
IOU Financial announces renewal and increase of its credit facility Canada NewsWire SOURCE IOU FINANCIAL INC.
Sign-up for IOU Financial announces renewal and increase of its credit facility investment picks
2014/2/12
http://media.marketwire.com/attachments/201205/45279_iPasslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1089341&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass Expands Network Footprint by Nearly 50% to 2.2 Million Hotspots investment picks
2014/2/12
http://media.marketwire.com/attachments/201205/45279_iPasslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1089514&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass Explores Strategic Alternatives for Its Unity Network Services Business investment picks
2014/2/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1089548&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass Reports Fourth Quarter and Year End 2013 Financial Results investment picks
2014/2/12
NORTH HOLLYWOOD, Calif., Feb.
Sign-up for IPC The Hospitalist Company, Inc. to Participate in Upcoming Investor Conferences investment picks
2014/2/12
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appointment of Julie McHugh to its board of directors.
Sign-up for Ironwood Pharmaceuticals Appoints Julie McHugh to Board of Directors investment picks
2014/2/12
NEW YORK and ST.
Sign-up for Irving Place Capital Agrees to Sale of Victor Technologies to Colfax Corporation for $947 Million in Cash investment picks
2014/2/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1089338&ProfileId=051205&sourceType=1 CALGARY, AB --
Sign-up for Ithaca Energy Inc. Announces Handcross Well Result investment picks
2014/2/12
Itron, Inc. (NASDAQ:ITRI) announced today financial results for its fourth quarter and full year ended December 31, 2013.
Sign-up for Itron Announces Fourth Quarter and Fiscal 2013 Financial Results investment picks
2014/2/12
Itron, Inc. (NASDAQ: ITRI) announced today that its board of directors has authorized a new repurchase program of up to $50 million of Itron common stock over a 12-month period to commence upon the expiration of the current share repurchase program on March 7, 2014.
Sign-up for Itron Authorizes $50 Million Share Repurchase Program investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: IIROC Trading Halt - EVT to Itron Authorizes $50 Million Share Repurchase Program
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity